Kariya Pharmaceuticals Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • (Upcoming)
  • Latest Deal Amount
  • $6.08M
Latest Deal Amount
  • Investors
  • 3

Kariya Pharmaceuticals General Information

Description

Developer neurodegenerative drugs designed to slow the progression of neurodegenerative diseases. The company's drug consists of dual incretin receptors that assist to slow disease progression, enabling patients to treat Parkinson's and Alzheimer's diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark

Kariya Pharmaceuticals Timeline

2019202020212022
Date FoundedFinancing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kariya Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) $6.08M Upcoming Startup
3. Grant 10-Dec-2019 00000 00.000 Completed Startup
2. Accelerator/Incubator 29-May-2019 $1.53M Completed Startup
1. Accelerator/Incubator 07-Feb-2019 $1.53M $1.53M Completed Startup
To view Kariya Pharmaceuticals’s complete valuation and funding history, request access »

Kariya Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Christian Hölscher Co-Founder, Chief Scientific Officer & Board Member
Mikael Thomsen Ph.D Co-Founder & CDO
Ian Laquian Co-Founder & Chief Executive Officer
To view Kariya Pharmaceuticals’s complete executive team members history, request access »

Kariya Pharmaceuticals Board Members (1)

Name Representing Role Since
Christian Hölscher Kariya Pharmaceuticals Co-Founder, Chief Scientific Officer & Board Member 000 0000
To view Kariya Pharmaceuticals’s complete board members history, request access »

Kariya Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovationsfonden Venture Capital Minority 000 0000 000000 0
Copenhagen Bio Science Park Accelerator/Incubator Minority 000 0000 000000 0
BioInnovation Institute (BII) Accelerator/Incubator Minority 000 0000 000000 0
To view Kariya Pharmaceuticals’s complete investors history, request access »